The Department of Justice filed an quick charm following a Texas federal judge’s surprising final decision to pull the Foodstuff and Drug Administration’s approval of mifepristone, a single of two drugs used in treatment abortion.
The Justice Section appealed directly to the U.S. Court of Appeals for the Fifth Circuit on Friday evening, only a handful of several hours after the first ruling.
U.S. Attorney General Merrick Garland claimed in a assertion that the DOJ “strongly disagrees with the decision” and “will be captivating the court’s determination and searching for a stay pending attractiveness.”
“Today’s decision overturns the FDA’s skilled judgment, rendered about two a long time in the past, that mifepristone is safe and sound and effective,” Garland wrote. “The Section will continue on to protect the FDA’s determination.”